Keith Heinzerling, M.D., M.P.H.


Work Titles
UCLA Health Sciences Associate Clinical Professor, Family Medicine
Education:
Degrees:
M.D.
M.P.H.

Contact Information:

Email Address:

heinzk@ucla.edu

Work Email Address:

HEINZK@UCLA.EDU


Website:

http://www.uclacbam.org/

Publications:

A selected list of publications:

Swanson Aimee-Noelle, Shoptaw Steven, Heinzerling Keith Gregory, Wade Adam C, Worley Matthew, McCracken James, Wilson Sarah A, Asarnow Joan, London Edythe D   Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles Substance use & misuse, 2013; 48(14): 1553-62.
Brensilver Matthew, Heinzerling Keith G, Shoptaw Steven   Pharmacotherapy of amphetamine-type stimulant dependence: an update Drug and alcohol review, 2013; 32(5): 449-60.
Heinzerling Keith G, Gadzhyan Janette, van Oudheusden Henry, Rodriguez Felipe, McCracken James, Shoptaw Steven   Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013; 52(4): 502-5.
Brensilver Matthew, Heinzerling Keith G, Swanson Aimee-Noelle, Telesca Donatello, Furst Benjamin A, Shoptaw Steven J   Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment Drug and alcohol review, 2013; 32(1): 96-9.
Brensilver Matthew, Heinzerling Keith G, Swanson Aimee-Noelle, Shoptaw Steven J   Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence Experimental and clinical psychopharmacology, 2012; 20(5): 430-5.
Brensilver Matthew, Heinzerling Keith G, Swanson Aimee-Noelle, Shoptaw Steven J   A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation Drug and alcohol dependence, 2012; 125(1-2): 169-72.
Heinzerling Keith G, Shoptaw Steven   Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use Gender medicine, 2012; 9(2): 112-20.
Heinzerling Keith G, McCracken James T, Swanson Aimee-Noelle, Ray Lara A, Shoptaw Steven J   COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation Journal of clinical psychopharmacology, 2012; 32(1): 135-7.
Ling Walter, Shoptaw Steven, Hillhouse Maureen, Bholat Michelle A, Charuvastra Charles, Heinzerling Keith, Chim David, Annon Jeffrey, Dowling Patrick T, Doraimani Geetha   Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence Addiction (Abingdon, England), 2012; 107(2): 361-9.
Heslin Kevin C, Stein Judith A, Heinzerling Keith G, Pan Deyu, Magladry Christine, Hays Ron D   Clinical correlates of health-related quality of life among opioid-dependent patients Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2011; 20(8): 1205-13.
Heinzerling Keith G, Swanson Aimee-Noelle, Kim Soeun, Cederblom Lisa, Moe Ardis, Ling Walter, Shoptaw Steven   Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence Drug and alcohol dependence, 2010; 109(1-3): 20-9.
Dean Andy C, London Edythe D, Sugar Catherine A, Kitchen Christina M R, Swanson Aimee-Noelle, Heinzerling Keith G, Kalechstein Ari D, Shoptaw Steven   Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables Drug and alcohol dependence, 2009; 105(1-2): 48-55.
De La Garza Richard, Zorick Todd, Heinzerling Keith G, Nusinowitz Steve, London Edythe D, Shoptaw Steven, Moody David E, Newton Thomas F   The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers Pharmacology, biochemistry, and behavior, 2009; 94(1): 186-93.
Shoptaw Steven J, Kao Uyen, Heinzerling Keith, Ling Walter   Treatment for amphetamine withdrawal The Cochrane database of systematic reviews, 2009; 94(2): CD003021.
Shoptaw Steven, Heinzerling Keith G, Rotheram-Fuller Erin, Steward Trevor, Wang Jason, Swanson Aimee-Noelle, De La Garza Richard, Newton Tom, Ling Walter   Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence Drug and alcohol dependence, 2008; 96(3): 222-32.
Bluthenthal Ricky N, Heinzerling Keith G, Anderson Rachel, Flynn Neil M, Kral Alex H   Approval of syringe exchange programs in California: results from a local approach to HIV prevention American journal of public health, 2008; 98(2): 278-83.
Shoptaw Steve, Heinzerling Keith G, Rotheram-Fuller Erin, Kao Uyen H, Wang Pin-Chieh, Bholat Michelle A, Ling Walter   Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence Journal of addictive diseases, 2008; 27(1): 13-23.
Heinzerling Keith G, Kral Alex H, Flynn Neil M, Anderson Rachel L, Scott Andrea, Gilbert Mary L, Asch Steven M, Bluthenthal Ricky N   Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes Journal of substance abuse treatment, 2007; 32(4): 423-9.
Heinzerling Keith G, Shoptaw Steven, Peck James A, Yang Xiaowei, Liu Juanmei, Roll John, Ling Walter   Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence Drug and alcohol dependence, 2006; 85(3): 177-84.
Heinzerling Keith G, Etzioni David A, Hurley Brian, Holtom Paul, Bluthenthal Ricky N, Asch Steven M   Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California Journal of urban health : bulletin of the New York Academy of Medicine, 2006; 83(2): 176-81.

Does this profile need updating? Contact Us